Richard Clinton Becker
Duke Clinical Research Institute
2 papers in the Anchorcite directory, published between 2009 and 2011, cited 16,702 times in total.
ORCID profileResearch topics
- Acute Ischemic Stroke Management · 1 paper
- Atrial Fibrillation Management and Outcomes · 1 paper
- Venous Thromboembolism Diagnosis and Management · 1 paper
- Acute Myocardial Infarction Research · 1 paper
- Antiplatelet Therapy and Cardiovascular Diseases · 1 paper
- Coronary Interventions and Diagnostics · 1 paper
Frequent co-authors
- Kenneth W. Mahaffey · 2 papers
- Manesh R. Patel · 1 paper
- Jyotsna Garg · 1 paper
- Guohua Pan · 1 paper
- Daniel E. Singer · 1 paper
- Werner Hacke · 1 paper
- GÜNTER E. BREITHARDT · 1 paper
- Jonathan L. Halperin · 1 paper
Papers
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine · 2011 · 9,529 citations
BACKGROUND: The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor Xa inhibitor, may provide more consistent and predictable anticoagulation than warfarin. METHODS: In…
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine · 2009 · 7,173 citations
BACKGROUND: Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet inhibition than clopidogrel. METHODS: In this multicenter, double-blind, randomized trial, we compared ticagrelor (180-mg loading dose,…
Metadata from OpenAlex (CC0).